$TNDM
TANDEM DIABETES CARE INC

2024 Q4 Form 10-Q Financial Statement

#000143813324000201 Filed on November 06, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $244.0M
YoY Change 31.43%
Cost Of Revenue $119.3M
YoY Change 24.46%
Gross Profit $124.7M
YoY Change 38.88%
Gross Profit Margin 51.09%
Selling, General & Admin $99.64M
YoY Change 25.6%
% of Gross Profit 79.93%
Research & Development $51.11M
YoY Change 21.77%
% of Gross Profit 41.0%
Depreciation & Amortization $4.211M
YoY Change 5.28%
% of Gross Profit 3.38%
Operating Expenses $150.7M
YoY Change 24.28%
Operating Profit -$26.09M
YoY Change -17.28%
Interest Expense $3.479M
YoY Change 334.88%
% of Operating Profit
Other Income/Expense, Net $3.479M
YoY Change 326.35%
Pretax Income -$22.60M
YoY Change -26.38%
Income Tax $600.0K
% Of Pretax Income
Net Earnings -$23.25M
YoY Change -29.46%
Net Earnings / Revenue -9.53%
Basic Earnings Per Share -$0.35
Diluted Earnings Per Share -$0.35
COMMON SHARES
Basic Shares Outstanding 65.68M shares 65.46M shares
Diluted Shares Outstanding 65.54M shares

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $473.3M
YoY Change -5.0%
Cash & Equivalents $49.04M
Short-Term Investments $424.3M
Other Short-Term Assets $19.89M
YoY Change 22.79%
Inventory $152.4M
Prepaid Expenses
Receivables $107.2M
Other Receivables $0.00
Total Short-Term Assets $752.8M
YoY Change -0.7%
LONG-TERM ASSETS
Property, Plant & Equipment $81.06M
YoY Change 7.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $36.45M
YoY Change 119.94%
Total Long-Term Assets $204.9M
YoY Change 12.73%
TOTAL ASSETS
Total Short-Term Assets $752.8M
Total Long-Term Assets $204.9M
Total Assets $957.7M
YoY Change 1.9%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $48.75M
YoY Change 5.66%
Accrued Expenses $12.28M
YoY Change -12.74%
Deferred Revenue $42.57M
YoY Change 34.66%
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $40.61M
YoY Change
Total Short-Term Liabilities $259.3M
YoY Change 38.57%
LONG-TERM LIABILITIES
Long-Term Debt $307.8M
YoY Change 8.16%
Other Long-Term Liabilities $32.24M
YoY Change 33.68%
Total Long-Term Liabilities $340.1M
YoY Change 1310.02%
TOTAL LIABILITIES
Total Short-Term Liabilities $259.3M
Total Long-Term Liabilities $340.1M
Total Liabilities $720.0M
YoY Change 15.04%
SHAREHOLDERS EQUITY
Retained Earnings -$1.049B
YoY Change 13.75%
Common Stock $1.282B
YoY Change 3.59%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $237.7M
YoY Change
Total Liabilities & Shareholders Equity $957.7M
YoY Change 1.9%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income -$23.25M
YoY Change -29.46%
Depreciation, Depletion And Amortization $4.211M
YoY Change 5.28%
Cash From Operating Activities $26.78M
YoY Change
INVESTING ACTIVITIES
Capital Expenditures $5.239M
YoY Change -2.98%
Acquisitions
YoY Change
Other Investing Activities -$14.66M
YoY Change -65.99%
Cash From Investing Activities -$19.90M
YoY Change -59.06%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -4.519M
YoY Change 137.84%
NET CHANGE
Cash From Operating Activities 26.78M
Cash From Investing Activities -19.90M
Cash From Financing Activities -4.519M
Net Change In Cash 2.364M
YoY Change -104.68%
FREE CASH FLOW
Cash From Operating Activities $26.78M
Capital Expenditures $5.239M
Free Cash Flow $21.54M
YoY Change -498.89%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001438133
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Registrant Name
EntityRegistrantName
Tandem Diabetes Care, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-4327508
dei Entity Address Address Line1
EntityAddressAddressLine1
12400 High Bluff Drive
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92130
dei Entity Address City Or Town
EntityAddressCityOrTown
San Diego,
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei City Area Code
CityAreaCode
858
dei Local Phone Number
LocalPhoneNumber
366-6900
dei Trading Symbol
TradingSymbol
TNDM
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
58868000 usd
CY2024Q3 us-gaap Short Term Investments
ShortTermInvestments
424266000 usd
CY2023Q4 us-gaap Short Term Investments
ShortTermInvestments
409044000 usd
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
107188000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
105555000 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
152441000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
157937000 usd
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
19892000 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
752826000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
747989000 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
81064000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
76542000 usd
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
87393000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
87791000 usd
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
36447000 usd
CY2024Q3 us-gaap Assets
Assets
957730000 usd
CY2023Q4 us-gaap Assets
Assets
952658000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
49586000 usd
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
12280000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
12726000 usd
CY2024Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
58718000 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
43430000 usd
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
65646000 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
65646000 shares
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
243971000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
185622000 usd
CY2024Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
119318000 usd
CY2024Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
99639000 usd
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
79328000 usd
CY2024Q3 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
51107000 usd
CY2023Q3 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
41970000 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-26093000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-31545000 usd
CY2024Q3 us-gaap Interest And Other Income
InterestAndOtherIncome
5344000 usd
CY2023Q3 us-gaap Interest And Other Income
InterestAndOtherIncome
5656000 usd
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.35
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
65538000 shares
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3700000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-30700000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-188900000 usd
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
65676532 shares
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
49039000 usd
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
48754000 usd
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
95869000 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
89753000 usd
CY2024Q3 us-gaap Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
0 usd
CY2023Q3 us-gaap Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
0 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
150746000 usd
us-gaap Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
0 usd
us-gaap Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
78750000 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
121298000 usd
us-gaap Operating Expenses
OperatingExpenses
430664000 usd
us-gaap Operating Expenses
OperatingExpenses
472565000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-98545000 usd
CY2022Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
36537000 usd
us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
26889000 usd
CY2023Q3 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
8986000 usd
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
27675000 usd
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
24054000 usd
CY2024Q3 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
1882000 usd
CY2023Q3 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
-1775000 usd
us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
174000 usd
CY2024Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
40746000 usd
CY2023Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
37757000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
40336000 usd
CY2024Q3 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
40605000 usd
CY2023Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
0 usd
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
18033000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
17060000 usd
CY2024Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
42567000 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
43994000 usd
CY2024Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
38319000 usd
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
28462000 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
259276000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
195258000 usd
CY2024Q3 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
307829000 usd
CY2023Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
285035000 usd
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
109479000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
113572000 usd
CY2024Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
11196000 usd
CY2023Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
13331000 usd
CY2024Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
32240000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
31830000 usd
CY2024Q3 us-gaap Liabilities
Liabilities
720020000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
639026000 usd
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
66000 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
66000 usd
CY2024Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1282354000 usd
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
3870000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1369000 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1048580000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-951800000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
237710000 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
957730000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
952658000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
657555000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
550922000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
325436000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
276527000 usd
CY2024Q3 us-gaap Gross Profit
GrossProfit
124653000 usd
us-gaap Gross Profit
GrossProfit
332119000 usd
us-gaap Gross Profit
GrossProfit
274395000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
283987000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
266752000 usd
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
146677000 usd
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
127063000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-198170000 usd
us-gaap Interest And Other Income
InterestAndOtherIncome
13482000 usd
us-gaap Interest And Other Income
InterestAndOtherIncome
17305000 usd
CY2024Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
1865000 usd
CY2023Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
4840000 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
5555000 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
8079000 usd
CY2024Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2023Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1268000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3479000 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
816000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
6659000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
9226000 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-22614000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-30729000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-91886000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-188944000 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
637000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2232000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4894000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3665000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-32961000 usd
us-gaap Net Income Loss
NetIncomeLoss
-96780000 usd
us-gaap Net Income Loss
NetIncomeLoss
-192609000 usd
CY2024Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
3948000 usd
CY2023Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
349000 usd
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
2189000 usd
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
1800000 usd
CY2024Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
1175000 usd
CY2023Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-1362000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
312000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-2189000 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-33974000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-94279000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-192998000 usd
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.35
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.51
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.51
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.48
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.48
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.97
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.97
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
65117000 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
65117000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
65287000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
65287000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
64834000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
64834000 shares
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
233875000 usd
CY2024Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
409000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
11684000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1711000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
4066000 usd
tndm Operating Lease Impairment And Termination Loss
OperatingLeaseImpairmentAndTerminationLoss
14099000 usd
us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
-3177000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
65335000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
78750000 usd
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-1437000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-9872000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
32714000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
7296000 usd
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
1216000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-4574000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
10042000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
10745000 usd
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
200000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-24594000 usd
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
391025000 usd
us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
415485000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
21605000 usd
us-gaap Payments To Acquire In Process Research And Development
PaymentsToAcquireInProcessResearchAndDevelopment
69496000 usd
tndm Payments To Acquire Intangible Assets And Strategic Investments
PaymentsToAcquireIntangibleAssetsAndStrategicInvestments
2515000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-69156000 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 usd
tndm Payments For Capped Call Transactions
PaymentsForCappedCallTransactions
0 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1567000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-71000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1496000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-652000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-92906000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
172517000 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
49039000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
79611000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
1771000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
3224000 usd
CY2024Q3 us-gaap Equity Method Investment Other Than Temporary Impairment
EquityMethodInvestmentOtherThanTemporaryImpairment
0 usd
CY2024Q3 us-gaap Guarantee Obligations Current Carrying Value
GuaranteeObligationsCurrentCarryingValue
30100000 usd
CY2024Q3 tndm Estimated Sales Rebates Noncurrent
EstimatedSalesRebatesNoncurrent
6503000 usd
CY2024Q3 tndm Estimated Sales Rebates
EstimatedSalesRebates
9515000 usd
CY2024Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
37356000 usd
CY2023Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
38917000 usd
CY2024Q3 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
11084000 usd
CY2023Q3 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
9601000 usd
us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
31074000 usd
CY2024Q3 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
9576000 usd
CY2024Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
40746000 usd
CY2024Q3 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
19832000 usd
CY2024Q3 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
20914000 usd
CY2024Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
40746000 usd
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5986000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
11223000 shares
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
4327000 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-22600000 usd
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
16585000 usd
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
65552000 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
65552000 shares
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1263997000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
313632000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-23251000 usd
CY2024Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-18128000 usd
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
65538000 shares
CY2024Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
-4927000 usd
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
26481000 usd
CY2024Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
3948000 usd
CY2024Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
1175000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-23251000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
237710000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
313632000 usd
us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
30000000 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1806000 usd
us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
-17124000 usd
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
6286000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
73018000 usd
tndm Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt Purchase Of Capped Call Option
AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtPurchaseOfCappedCallOption
15813000 usd
tndm Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt Partial Termination Of Capped Call Options
AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtPartialTerminationOfCappedCallOptions
184000 usd
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
2189000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
312000 usd
us-gaap Net Income Loss
NetIncomeLoss
-96780000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
237710000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
329234000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
106000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
-1945000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
0 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
20579000 usd
CY2023Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
349000 usd
CY2023Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-1362000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-32961000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
314000000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
439947000 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1267000 usd
us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
-6505000 usd
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
6804000 usd
tndm Stock Issued During Period Value Common Stock Warrants Exercised
StockIssuedDuringPeriodValueCommonStockWarrantsExercised
0 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
65485000 usd
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
1800000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-2189000 usd
us-gaap Net Income Loss
NetIncomeLoss
-192609000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
314000000 usd
us-gaap Profit Loss
ProfitLoss
-96780000 usd
us-gaap Profit Loss
ProfitLoss
-192609000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
12362000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1587000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
7302000 usd
tndm Operating Lease Impairment And Termination Loss
OperatingLeaseImpairmentAndTerminationLoss
2000000 usd
us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
595000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
73217000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1268000 usd
us-gaap Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
0 usd
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
1610000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
8712000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-5215000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3427000 usd
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-440000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-952000 usd
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
15300000 usd
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
5571000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-3589000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
6898000 usd
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
364000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
13508000 usd
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
251361000 usd
us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
239031000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
16162000 usd
us-gaap Payments To Acquire In Process Research And Development
PaymentsToAcquireInProcessResearchAndDevelopment
0 usd
tndm Payments To Acquire Intangible Assets And Strategic Investments
PaymentsToAcquireIntangibleAssetsAndStrategicInvestments
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-28492000 usd
CY2024Q3 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
9400000 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
306850000 usd
CY2024Q3 us-gaap Debt Instrument Repurchased Face Amount
DebtInstrumentRepurchasedFaceAmount
246740000 usd
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
246123000 usd
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
0 usd
tndm Payments For Capped Call Transactions
PaymentsForCappedCallTransactions
15813000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
30000000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
-9032000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
183000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
6065000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-910000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-9829000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
58868000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
1298000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
4659000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
2641000 usd
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses and the disclosure of contingent assets and liabilities in the Company’s condensed consolidated financial statements and accompanying notes as of the date of the condensed consolidated financial statements. Some of those judgments can be subjective and complex, and therefore, actual results could differ materially from those estimates under different assumptions or conditions.</span></div>
CY2024Q3 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
30400000 usd
CY2023Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
10100000 usd
us-gaap Equity Method Investment Other Than Temporary Impairment
EquityMethodInvestmentOtherThanTemporaryImpairment
2000000 usd
CY2023Q3 us-gaap Equity Method Investment Other Than Temporary Impairment
EquityMethodInvestmentOtherThanTemporaryImpairment
0 usd
us-gaap Equity Method Investment Other Than Temporary Impairment
EquityMethodInvestmentOtherThanTemporaryImpairment
0 usd
CY2024Q3 tndm Investment Owned Ownership Interest
InvestmentOwnedOwnershipInterest
0.15
CY2023Q4 tndm Investment Owned Ownership Interest
InvestmentOwnedOwnershipInterest
0.15
CY2023Q4 us-gaap Guarantee Obligations Current Carrying Value
GuaranteeObligationsCurrentCarryingValue
30600000 usd
CY2024Q3 tndm Estimated Sales Rebates Current
EstimatedSalesRebatesCurrent
3012000 usd
CY2023Q4 tndm Estimated Sales Rebates Current
EstimatedSalesRebatesCurrent
505000 usd
CY2023Q4 tndm Estimated Sales Rebates Noncurrent
EstimatedSalesRebatesNoncurrent
8042000 usd
CY2023Q4 tndm Estimated Sales Rebates
EstimatedSalesRebates
8547000 usd
CY2023Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
37173000 usd
us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
-1615000 usd
CY2023Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
37757000 usd
CY2023Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
18135000 usd
CY2023Q4 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
19038000 usd
CY2023Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
37173000 usd
CY2024Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
14744000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4974000 shares
CY2024Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
421328000 usd
CY2024Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
2956000 usd
CY2024Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
18000 usd
CY2024Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
424266000 usd
CY2023Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
408295000 usd
CY2023Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
1025000 usd
CY2023Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
276000 usd
CY2023Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
409044000 usd
CY2024Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
218027000 usd
CY2024Q3 tndm Debt Securities Available For Sale Fair Value Maturity Allocated And Single Maturity Date After Year One Through Two
DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughTwo
118843000 usd
CY2024Q3 tndm Debt Securities Available For Sale Fair Value Maturity Allocated And Single Maturity Date After Year Two Through Three
DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearTwoThroughThree
87396000 usd
CY2024Q3 us-gaap Available For Sale Securities Debt Maturities Single Maturity Date
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate
424266000 usd
CY2024Q3 us-gaap Accounts Receivable Gross
AccountsReceivableGross
113249000 usd
CY2023Q4 us-gaap Accounts Receivable Gross
AccountsReceivableGross
110453000 usd
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
6061000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
4898000 usd
CY2024Q3 us-gaap Accounts Receivable Net
AccountsReceivableNet
107188000 usd
CY2023Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
105555000 usd
CY2024Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
5225000 usd
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
4842000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
4898000 usd
CY2024Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
3579000 usd
CY2023Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1308000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
7302000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
4066000 usd
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
2743000 usd
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
795000 usd
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
6139000 usd
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
3038000 usd
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
6061000 usd
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
5355000 usd
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
6061000 usd
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
5355000 usd
CY2024Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
35933000 usd
CY2023Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
42783000 usd
CY2024Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
35829000 usd
CY2023Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
44026000 usd
CY2024Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
80679000 usd
CY2023Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
71128000 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
152441000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
157937000 usd
CY2024Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
3603000 usd
CY2023Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
3528000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
10684000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
12457000 usd
CY2024Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
22000 usd
CY2023Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
22000 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
65000 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
87000 usd
CY2024Q3 tndm Gain Loss On Termination Of Lease And Operating Lease Impairment Loss
GainLossOnTerminationOfLeaseAndOperatingLeaseImpairmentLoss
0 usd
CY2023Q3 tndm Gain Loss On Termination Of Lease And Operating Lease Impairment Loss
GainLossOnTerminationOfLeaseAndOperatingLeaseImpairmentLoss
0 usd
tndm Gain Loss On Termination Of Lease And Operating Lease Impairment Loss
GainLossOnTerminationOfLeaseAndOperatingLeaseImpairmentLoss
0 usd
tndm Gain Loss On Termination Of Lease And Operating Lease Impairment Loss
GainLossOnTerminationOfLeaseAndOperatingLeaseImpairmentLoss
-11224000 usd
CY2024Q3 us-gaap Lease Cost
LeaseCost
3625000 usd
CY2023Q3 us-gaap Lease Cost
LeaseCost
3550000 usd
us-gaap Lease Cost
LeaseCost
10749000 usd
us-gaap Lease Cost
LeaseCost
23768000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
4433000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
18188000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
18146000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
18449000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
14934000 usd
CY2024Q3 tndm Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
90326000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
164476000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
36964000 usd
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
127512000 usd
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
18033000 usd
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
109479000 usd
CY2024Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P9Y4M24D
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P10Y2M12D
CY2024Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.053
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.054
tndm Operating Lease Cash Payments
OperatingLeaseCashPayments
13300000 usd
tndm Operating Lease Cash Payments
OperatingLeaseCashPayments
9200000 usd
CY2024Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
40605000 usd
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
0 usd
CY2024Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
307829000 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
285035000 usd
CY2024Q3 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
22241000 shares
CY2024Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right
ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
1 shares
CY2023Q2 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
2602184 shares
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
3000000 shares
CY2024Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
26281000 usd
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
20741000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
73217000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
65335000 usd
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
1800000 usd
CY2023 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
2000000.0 usd
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
3000000 shares
tndm Defined Contribution Plan Minimum Age Of Employee
DefinedContributionPlanMinimumAgeOfEmployee
P18Y
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
600000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4900000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-91900000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2200000 usd
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
243971000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
185622000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
657555000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
550922000 usd
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
243971000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
185622000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
657555000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
550922000 usd
CY2022Q3 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
8000000 chf
CY2024Q2 us-gaap Loss Contingency New Claims Filed Number
LossContingencyNewClaimsFiledNumber
2 lawsuit
CY2024Q3 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
4900000 usd
CY2024Q3 us-gaap Guarantee Obligations Current Carrying Value
GuaranteeObligationsCurrentCarryingValue
30100000 usd

Files In Submission

Name View Source Status
0001438133-24-000201-index-headers.html Edgar Link pending
0001438133-24-000201-index.html Edgar Link pending
0001438133-24-000201.txt Edgar Link pending
0001438133-24-000201-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tndm-20240930.htm Edgar Link pending
tndm-20240930.xsd Edgar Link pending
tndm-20240930xex311.htm Edgar Link pending
tndm-20240930xex312.htm Edgar Link pending
tndm-20240930xex321.htm Edgar Link pending
tndm-20240930xex322.htm Edgar Link pending
tndm-20240930_cal.xml Edgar Link unprocessable
tndm-20240930_def.xml Edgar Link unprocessable
tndm-20240930_lab.xml Edgar Link unprocessable
tndm-20240930_pre.xml Edgar Link unprocessable
tndm-20240930_htm.xml Edgar Link completed